Unisom
Unisom Price range: $ 46,00 through $ 232,00
Back to products
Uroxatral
Uroxatral Price range: $ 52,00 through $ 324,00

Urispas

Price range: $ 48,00 through $ 385,00

Urispas is an effective medication designed to alleviate symptoms of bladder and urinary tract discomfort. It works by relaxing the muscles in the bladder, helping to reduce pain, urgency, and frequent urination. This product is available over the counter and can be purchased without a doctor prescription for your convenience. Experience relief from bothersome urinary symptoms with Urispas.

Active substance: Flavoxate
SKU: Urispas Categories: ,
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: EXTRA10

Each dosage option has its own packaging choices.

Description

Urispas Relief for Overactive Bladder Reducing Urinary Frequency and Urgency

Welcome to our in-depth guide on Urispas, a medication specifically designed to provide symptomatic relief for various uncomfortable conditions affecting the urinary tract. Understanding your medication is crucial for effective management of symptoms and overall well-being. This guide aims to offer a detailed overview of Urispas, helping you comprehend its mechanism, benefits, proper usage, and important considerations.

Our focus is to deliver clear, accurate, and comprehensive information about Urispas (known by its generic name, flavoxate hydrochloride), empowering you with the knowledge to discuss your treatment effectively with your healthcare provider. This resource is tailored for residents across the USA and beyond, ensuring you have access to vital details about this important medication.

What is Urispas and How Does It Work?

Urispas is a medication whose active ingredient is flavoxate hydrochloride. It belongs to a class of drugs known as urinary tract antispasmodics. Its primary function is to alleviate a range of bothersome symptoms associated with inflammation or irritation of the urinary tract. These symptoms often arise from specific medical conditions such as cystitis, prostatitis, urethritis, urethrocystitis, and urethrotrigonitis, or from medical procedures like cystoscopy and the insertion of indwelling catheters.

The mechanism of action of flavoxate hydrochloride is unique and targeted. It exerts a direct relaxant effect on the smooth muscle of the urinary tract, particularly within the bladder. The bladder wall contains smooth muscle fibers that contract to expel urine. When these muscles become overactive or spasm, they can lead to uncomfortable and often painful symptoms. Urispas works by directly inhibiting these spasmodic contractions, thereby reducing the irritability and overactivity of the bladder muscles.

This direct antispasmodic action helps to mitigate the involuntary contractions that contribute to symptoms like dysuria (painful urination), urgency (a sudden, compelling urge to urinate), nocturia (frequent urination at night), suprapubic pain (pain in the lower abdomen, above the pubic bone), frequency (urinating more often than usual), and incontinence (involuntary leakage of urine). By calming the bladder muscles, Urispas helps restore a more normal pattern of urination and provides significant relief from these distressing symptoms. It’s important to understand that while Urispas effectively manages these symptoms, it does not treat the underlying infection or condition causing them, if one exists. Therefore, it is often used in conjunction with other treatments aimed at addressing the root cause of the urinary tract inflammation or irritation.

Key Benefits and Approved Uses

Urispas, with its active component flavoxate hydrochloride, offers significant symptomatic relief for a variety of conditions affecting the lower urinary tract. The approved indications for Urispas are focused on addressing the uncomfortable symptoms that arise from irritation or inflammation, rather than curing the underlying cause. This medication is a valuable tool in improving the quality of life for individuals experiencing these specific urinary discomforts.

The primary benefit of Urispas is its ability to reduce or eliminate the following disruptive urinary symptoms:

  • Dysuria: Painful or difficult urination, a common symptom of urinary tract inflammation.
  • Urgency: A sudden, strong, and often uncontrollable need to urinate, which can be particularly distressing.
  • Nocturia: The need to wake up one or more times during the night to urinate, disrupting sleep patterns.
  • Suprapubic Pain: Discomfort or pain experienced in the lower abdominal area, specifically above the pubic bone, often indicative of bladder irritation.
  • Frequency: An increased need to urinate more often than usual throughout the day.
  • Incontinence: The involuntary leakage of urine, which can be particularly embarrassing and challenging to manage.

Urispas is specifically indicated for the symptomatic relief of these issues when they are associated with a range of inflammatory conditions of the urinary tract. These conditions include:

  • Cystitis: Inflammation of the bladder, most commonly caused by a bacterial infection.
  • Prostatitis: Inflammation of the prostate gland, which can cause pain and difficulty urinating.
  • Urethritis: Inflammation of the urethra, the tube that carries urine from the bladder out of the body.
  • Urethrocystitis: Combined inflammation of both the urethra and the bladder.
  • Urethrotrigonitis: Inflammation specifically affecting the urethra and the trigone of the bladder, an area often sensitive to irritation.

Beyond these inflammatory conditions, Urispas is also effectively used to alleviate bladder spasms that may arise from certain medical interventions or procedures. These include:

  • Indwelling Catheters: Catheters that remain in the bladder for an extended period can irritate the bladder and cause spasms.
  • Cystoscopy: A procedure where a thin tube with a camera is inserted into the bladder, which can sometimes lead to temporary bladder spasms.
  • Surgery of the Urogenital Tract: Post-surgical recovery involving the bladder or surrounding areas can often be complicated by spasms, and Urispas can help manage this discomfort.

By targeting the smooth muscle spasms, Urispas provides a direct approach to symptom management, offering comfort and helping individuals maintain their daily routines without the constant disruption of urinary discomfort. It’s a foundational medication for managing the disruptive symptoms of an overactive or irritated bladder, thereby enhancing patient comfort during recovery or chronic management.

Understanding Dosage and Administration

Proper dosage and administration are critical for maximizing the effectiveness of Urispas and minimizing potential side effects. Always adhere to the specific instructions provided by your healthcare provider, as individual needs may vary. This general guide provides an overview of typical usage patterns for flavoxate hydrochloride.

For adults and children 12 years of age and over, the usual recommended dosage of Urispas is 100 mg or 200 mg, taken three or four times daily. The exact dosage and frequency will depend on the severity of your symptoms and your response to the medication. It is important to maintain a consistent dosing schedule to ensure a steady level of the medication in your system, which helps in providing continuous relief from urinary symptoms. For example, if prescribed 200 mg four times a day, try to space your doses out evenly throughout the day, perhaps with meals, to help with adherence.

Urispas tablets should be swallowed whole with water. They can generally be taken with or without food. However, if you experience stomach upset or nausea, taking the medication with food may help alleviate these symptoms. Do not crush, chew, or break the tablets unless specifically instructed by your healthcare professional, as this can alter the drug’s release and effectiveness.

The duration of treatment with Urispas can vary. For acute conditions like cystitis or urethritis, it might be used for a shorter period until the inflammation subsides or the underlying infection is treated. For chronic conditions or recurrent bladder spasms, your healthcare provider might recommend longer-term use. It is crucial not to stop taking Urispas prematurely, even if your symptoms improve, unless advised by your doctor. Discontinuing the medication too soon might lead to a return of symptoms.

If you miss a dose of Urispas, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can increase the risk of side effects. Consistent adherence to the prescribed regimen is key for optimal results. Always consult your healthcare provider if you have any questions or concerns about your dosage or how to administer Urispas.

Potential Side Effects of Urispas

Like all medications, Urispas (flavoxate hydrochloride) can cause side effects, although not everyone experiences them. Most side effects are mild and temporary, resolving as your body adjusts to the medication. However, it’s important to be aware of potential reactions and know when to seek medical attention.

Common side effects associated with Urispas typically stem from its anticholinergic properties, which affect various bodily functions. These often include:

  • Nausea or Vomiting: Some individuals may experience stomach upset. Taking the medication with food can sometimes help mitigate this.
  • Dry Mouth: This is a common anticholinergic effect, often managed by staying hydrated, chewing sugar-free gum, or sucking on hard candies.
  • Blurred Vision: This can temporarily affect your eyesight, particularly when starting the medication. Exercise caution when driving or operating machinery if you experience this.
  • Dizziness or Drowsiness: Urispas can cause lightheadedness or make you feel sleepy. Avoid activities requiring mental alertness until you know how the medication affects you.
  • Headache: Mild headaches can occur in some users.
  • Nervousness or Vertigo: Feelings of unease or a sensation of spinning may occur.
  • Skin Rash or Hives: Mild allergic skin reactions are possible.

Less common or more serious side effects, although rare, warrant immediate medical attention. These include:

  • Allergic Reactions: Signs of a severe allergic reaction include difficulty breathing, swelling of the face, lips, tongue, or throat, and severe rash. Seek emergency medical care if these occur.
  • Eye Pain or Vision Changes: While blurred vision is common, severe eye pain or significant, sudden changes in vision could indicate a more serious issue, such as increased intraocular pressure (especially if you have untreated glaucoma).
  • Confusion or Hallucinations: In rare cases, particularly in older adults, Urispas may cause mental confusion or hallucinations.
  • Palpitations or Tachycardia: An unusually fast or irregular heartbeat.
  • Difficulty Urinating: Although Urispas is meant to ease urination, in some rare instances, it might paradoxically cause or worsen urinary retention, especially in individuals with pre-existing obstructive conditions.

If you experience any severe or persistent side effects, or if you notice any unusual symptoms while taking Urispas, it is crucial to contact your healthcare provider promptly. They can assess your symptoms, adjust your dosage if necessary, or recommend alternative treatments. Always provide your doctor with a complete list of all medications, supplements, and herbal products you are taking to help them evaluate potential drug interactions or contraindications.

Important Precautions and Contraindications

While Urispas is an effective medication for managing urinary symptoms, certain conditions and circumstances require caution or completely prohibit its use. Understanding these precautions and contraindications is vital for safe and effective treatment with flavoxate hydrochloride.

Contraindications (When Urispas Should NOT Be Used):

Urispas is contraindicated in individuals with certain obstructive conditions, as its anticholinergic effects can worsen these issues. These include:

  • Obstructive Conditions of the Gastrointestinal (GI) Tract: This includes pyloric or duodenal obstruction, obstructive intestinal lesions, or ileus (a lack of movement in the intestines). Urispas can decrease GI motility, potentially exacerbating these conditions and leading to severe complications.
  • Gastrointestinal Hemorrhage: The medication should not be used in cases of active GI bleeding.
  • Achalasia: A condition where the esophagus loses its ability to move food into the stomach, which could be worsened by Urispas.
  • Obstructive Uropathies of the Lower Urinary Tract: Conditions that cause significant blockage in the outflow of urine from the bladder, such as severe prostatic hypertrophy leading to significant urinary retention. Urispas can impair bladder emptying further.

Additionally, individuals with a known hypersensitivity or allergic reaction to flavoxate hydrochloride or any other component of the tablet should not use Urispas.

Precautions (When to Exercise Caution):

Several situations warrant careful consideration and monitoring when using Urispas:

  • Glaucoma: Patients with glaucoma, particularly angle-closure glaucoma, should use Urispas with extreme caution. The anticholinergic effects of flavoxate hydrochloride can increase intraocular pressure. It is advisable to have any existing glaucoma adequately controlled and monitored by an ophthalmologist while taking this medication.
  • Renal or Hepatic Impairment: Individuals with significant kidney or liver dysfunction may metabolize or excrete Urispas less efficiently, potentially leading to higher drug levels and an increased risk of side effects. Dosage adjustments or closer monitoring may be necessary.
  • Elderly Patients: Older adults may be more susceptible to the anticholinergic side effects of Urispas, such as confusion, dizziness, and dry mouth. They might also have age-related conditions that increase the risk of urinary retention or glaucoma. Careful dosing and monitoring are recommended.
  • Driving and Operating Machinery: Urispas can cause blurred vision, dizziness, or drowsiness. Patients should be advised to exercise caution when driving or performing tasks that require mental alertness until they know how the medication affects them.
  • Pregnancy and Lactation: Urispas is generally classified as Pregnancy Category B. This means animal reproduction studies have not demonstrated a fetal risk, but there are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if clearly needed and the potential benefits outweigh the potential risks to the fetus. It is not known whether flavoxate hydrochloride is excreted in human milk. Caution should be exercised when Urispas is administered to a nursing woman. Always consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding.

Always ensure your healthcare provider is aware of your complete medical history, including all existing conditions, allergies, and any other medications you are currently taking, before starting Urispas. This comprehensive disclosure allows your doctor to make an informed decision regarding the appropriateness and safety of this treatment for you.

Drug Interactions

While Urispas (flavoxate hydrochloride) is generally considered to have a relatively low potential for significant drug interactions, it is still crucial to be aware of possible interactions, especially with other medications that have anticholinergic properties. Drug interactions can alter the effectiveness of your medications or increase the risk of adverse effects.

The primary concern regarding drug interactions with Urispas relates to its anticholinergic activity. When Urispas is taken concurrently with other drugs that also possess anticholinergic effects, there is a possibility of additive effects. This can intensify anticholinergic side effects such as:

  • Increased Dry Mouth: Medications like tricyclic antidepressants (e.g., amitriptyline), certain antihistamines (e.g., diphenhydramine), antiparkinsonian drugs (e.g., benztropine), and some antipsychotics can exacerbate dry mouth when combined with Urispas.
  • Enhanced Blurred Vision: The risk of visual disturbances, especially blurred vision, may increase.
  • Greater Drowsiness or Dizziness: Central nervous system depressants, including sedatives, hypnotics, tranquilizers, and alcohol, can amplify the sedative effects of Urispas, leading to increased drowsiness, dizziness, or impaired coordination.
  • Increased Risk of Urinary Retention: For individuals susceptible to urinary retention, combining Urispas with other anticholinergic agents could further impair bladder emptying.
  • Worsening Constipation: The reduction in gastrointestinal motility caused by anticholinergic drugs can lead to or worsen constipation.

Specific classes of drugs to discuss with your healthcare provider if you are taking Urispas include:

  • Other Antispasmodics: Medications used for irritable bowel syndrome or other smooth muscle spasms.
  • Antidepressants: Particularly tricyclic antidepressants and some selective serotonin reuptake inhibitors (SSRIs) which may have anticholinergic effects.
  • Antihistamines: Especially older, first-generation antihistamines.
  • Antipsychotics: Some conventional and atypical antipsychotics.
  • Medications for Parkinson’s Disease: Many of these drugs have anticholinergic properties.

Before starting Urispas, it is paramount to inform your healthcare provider about all prescription medications, over-the-counter drugs, herbal supplements, vitamins, and recreational substances you are currently using. This comprehensive list enables your doctor to evaluate potential interactions and make necessary adjustments to your treatment plan or provide specific monitoring instructions. Never start or stop any medication without consulting your healthcare provider.

Urispas at a Glance: Key Characteristics

This table provides a concise summary of the essential characteristics of Urispas (flavoxate hydrochloride), offering a quick reference for important information about this medication.

Characteristic Description
Active Ingredient Flavoxate Hydrochloride
Drug Class Urinary Antispasmodic
Primary Use Symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence associated with cystitis, prostatitis, urethritis, urethrocystitis, urethrotrigonitis, and bladder spasms following medical procedures.
Mechanism of Action Direct relaxant effect on the smooth muscle of the urinary tract, reducing bladder spasms.
Typical Adult Dosage 100 mg or 200 mg, three or four times daily (as directed by a healthcare professional).
Common Side Effects Nausea, vomiting, dry mouth, blurred vision, dizziness, drowsiness, headache, nervousness, vertigo, skin rash.
Contraindications Obstructive conditions of the GI or urinary tract (e.g., pyloric/duodenal obstruction, ileus, achalasia, obstructive uropathies), GI hemorrhage, known hypersensitivity to flavoxate hydrochloride.
Precautions Glaucoma (especially angle-closure), renal or hepatic impairment, elderly patients, activities requiring mental alertness (driving/operating machinery).
Pregnancy Category B (use only if clearly needed).
Storage Store at room temperature, away from moisture and direct heat.

Frequently Asked Questions About Urispas

Here are answers to some of the most popular questions about Urispas (flavoxate hydrochloride), designed to provide further clarity and assist you in understanding your treatment.

1. How quickly does Urispas start to work?

The onset of action for Urispas can vary among individuals, but many people begin to experience relief from urinary symptoms within an hour or two after taking a dose. Consistent use as prescribed is important to maintain therapeutic levels and achieve sustained symptom relief, particularly for conditions causing persistent bladder spasms or irritation. It’s not an immediate cure for pain, but rather a medication that works to relax the bladder muscles over time.

2. How long should I take Urispas?

The duration of treatment with Urispas depends on the specific condition being managed and its severity. For acute conditions like cystitis or urethritis, it might be prescribed for a short period, often alongside an antibiotic if an infection is present, until symptoms subside. For chronic conditions, or for ongoing management of bladder spasms, your healthcare provider may recommend longer-term use. Always follow your doctor’s instructions regarding the duration of your treatment, and do not stop taking the medication prematurely without consulting them, even if you feel better.

3. Can Urispas cure my urinary tract infection (UTI)?

No, Urispas does not cure urinary tract infections. It is an antispasmodic medication designed to provide symptomatic relief from the discomforts associated with UTIs, such as dysuria, urgency, and frequency, by relaxing the bladder muscles. If your urinary symptoms are caused by a bacterial infection, you will likely need an antibiotic prescribed by your healthcare provider to eradicate the infection. Urispas works as a supportive treatment to make you more comfortable while the underlying infection is being treated.

4. Is Urispas suitable for children?

Urispas is generally approved for use in adults and children 12 years of age and older. For children under 12, the safety and efficacy of flavoxate hydrochloride have not been established. Any use in younger children would require careful consideration and specific guidance from a pediatrician. Always consult with a qualified healthcare professional before administering any medication to children.

5. Can I take Urispas if I have glaucoma?

If you have glaucoma, especially angle-closure glaucoma, you should use Urispas with extreme caution and only under the direct supervision of your healthcare provider. Flavoxate hydrochloride has anticholinergic properties that can increase intraocular pressure, potentially worsening glaucoma. It is essential to inform your doctor about your glaucoma history, and they may recommend regular eye pressure monitoring or consider alternative treatments if necessary to ensure your safety.

6. What should I do if I experience dry mouth while taking Urispas?

Dry mouth is a common anticholinergic side effect of Urispas. To manage this discomfort, you can try several strategies: sip water frequently, chew sugar-free gum, suck on sugar-free hard candies, or use over-the-counter artificial saliva products. Avoiding caffeine and alcohol can also help, as these can exacerbate dry mouth. If dry mouth becomes severe or persistent, discuss it with your healthcare provider, as they may have other recommendations or suggest an adjustment to your treatment plan.

7. Does Urispas interact with alcohol?

While specific severe interactions between Urispas and alcohol are not widely documented, it is generally advisable to exercise caution. Alcohol can heighten the central nervous system depressant effects of Urispas, potentially leading to increased drowsiness, dizziness, or impaired coordination. Combining the two may also exacerbate side effects such as nausea or headache. It is best to avoid or limit alcohol consumption while taking Urispas to minimize these potential risks.

8. Can Urispas cause drowsiness, and should I avoid driving?

Yes, Urispas can cause drowsiness, dizziness, or blurred vision in some individuals. These are common anticholinergic side effects. It is strongly advised to avoid driving, operating heavy machinery, or engaging in any activities that require full mental alertness until you know how Urispas affects you. If you experience these side effects, discuss them with your healthcare provider, who can offer advice or adjust your treatment if necessary.

9. Is it safe to take Urispas long-term?

Long-term use of Urispas should always be determined and monitored by a healthcare professional. While some individuals may require extended treatment for chronic conditions that cause persistent bladder spasms or irritation, the decision for long-term therapy is based on a careful assessment of benefits versus potential risks and side effects. Regular follow-ups with your doctor are crucial to ensure continued safety and effectiveness, and to re-evaluate the need for ongoing treatment.

Urispas (flavoxate hydrochloride) stands as a valuable medication for individuals experiencing the disruptive and uncomfortable symptoms associated with various urinary tract conditions. By effectively relaxing the smooth muscles of the bladder, it provides much-needed relief from dysuria, urgency, nocturia, suprapubic pain, frequency, and incontinence. Its role is purely symptomatic, aiming to improve comfort and quality of life while any underlying causes, such as infections, are addressed by other appropriate treatments. Always ensure you consult your healthcare provider for personalized medical advice and adhere strictly to their instructions to ensure the safest and most effective use of Urispas for your specific health needs.

Additional information
Dosage

200mg

Package

30 pills

,

60 pills

,

90 pills

,

120 pills

,

180 pills

,

270 pills

,

360 pills

Ενεργός Ουσία